Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
2.060
+0.030 (1.48%)
At close: Apr 28, 2026, 4:00 PM EDT
2.060
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:00 PM EDT
Acurx Pharmaceuticals Market Cap
Acurx Pharmaceuticals has a market cap or net worth of $7.56 million as of April 28, 2026. Its market cap has increased by 2.26% in one year.
Market Cap
7.56M
Enterprise Value
-177.20K
1-Year Change
2.26%
Ranking
Category
Stock Price
$2.06
Market Cap Chart
Since the IPO on June 25, 2021, Acurx Pharmaceuticals's market cap has decreased from $57.25M to $7.56M, a decrease of -86.79%. That is a compound annual growth rate of -34.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 7.45M | 27.46% |
| Dec 31, 2025 | 5.85M | -57.48% |
| Dec 31, 2024 | 13.75M | -73.92% |
| Dec 29, 2023 | 52.73M | 14.29% |
| Dec 30, 2022 | 46.14M | 4.51% |
| Dec 31, 2021 | 44.15M | -22.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Processa Pharmaceuticals | 7.93M |
| TransCode Therapeutics | 7.81M |
| PharmaCyte Biotech | 7.75M |
| GridAI Technologies | 7.63M |
| Indaptus Therapeutics | 7.40M |
| Addex Therapeutics | 7.39M |
| Aptorum Group | 7.31M |
| Immuron | 7.23M |